N&PD Moderators: Skorpio | someguyontheinternet
A commercial by an attorney looking for people who have had deaths in their family due to the Z-drugs also threw Restoril in there. Is this based on any research or did they unfairly lump this in with the Z-drugs. A google search doesn't show anything correlating Restoril and cancer.
Also has there been any new studies since 2008 clarifying if it is insomnia or sleeping pills causing the higher instances of cancer?
Implications
Currently, there is no evidence that sleeping habitually between 6 and 8h per day in an adult is associated with harm and long term health consequences. In terms of prevention, consistently sleeping 6 to 8 h per night may therefore be optimal for health. However, sleeping 9 h or more per night may represent a useful diagnostic tool for detecting subclinical or undiagnosed co-morbidity. People reporting consistently sleeping 5 hours or less per night should be regarded as a higher risk group for all-cause mortality. A 12% increased risk of death in short sleepers, if causally related, would equate to over 6.3 million attributable deaths in the UK in people over 16 years of age and over 25 million attributable deaths in the US in people over the age of 20 years. Future studies should be designed to answer the question whether sleep duration is a cause or simply a marker of ill-health. Indirect evidence seems to suggest to date that sustained sleep deprivation may trigger biological mechanisms contributing to the deterioration of health status, whereas long duration of sleep may be a powerful additional marker of ill-health.
Duration of sleep should be regarded as an additional behavioral risk factor or risk marker heavily determined by the environment and possibly amenable to modification through both education and counselling as well as through measures of public health. The latter would aim at favorable modifications of physical and working environments to allow sufficient sleep and avoid habitual and sustained sleep deprivation.
http://www.ncbi.nlm.nih.gov/pubmed/22371848Conclusions: Receiving hypnotic prescriptions was associated with greater than threefold increased hazards of death even when prescribed <18 pills/year. This association held in separate analyses for several commonly used hypnotics and for newer shorter-acting drugs. Control of selective prescription of hypnotics for patients in poor health did not explain the observed excess mortality.